ScoreWhy is Arrowhead Pharmaceuticals, Inc. ?
1
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 149.02%, its profits have risen by 67.6%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Arrowhead Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Arrowhead Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Arrowhead Pharmaceuticals, Inc.
148.02%
1.29
70.70%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.89%
EBIT Growth (5y)
-204.27%
EBIT to Interest (avg)
-57.63
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.32
Tax Ratio
1.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
99.29%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.40
EV to EBIT
-15.66
EV to EBITDA
-19.06
EV to Capital Employed
8.48
EV to Sales
3.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-54.16%
ROE (Latest)
-22.64%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend22What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 21.84 MM
NET SALES(HY)
Higher at USD 570.48 MM
NET PROFIT(HY)
Higher at USD 195.2 MM
ROCE(HY)
Highest at -34.8%
RAW MATERIAL COST(Y)
Fallen by -7,759% (YoY
CASH AND EQV(HY)
Highest at USD 1,997.78 MM
-19What is not working for the Company
INTEREST(Q)
Highest at USD 24.38 MM
PRE-TAX PROFIT(Q)
Lowest at USD -179.09 MM
NET PROFIT(Q)
Lowest at USD -175.24 MM
Here's what is working for Arrowhead Pharmaceuticals, Inc.
Net Sales
Higher at USD 570.48 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Operating Cash Flow
Highest at USD 21.84 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Cash and Eqv
Highest at USD 1,997.78 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -7,759% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 6.22 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Arrowhead Pharmaceuticals, Inc.
Pre-Tax Profit
At USD -179.09 MM has Fallen at -370.44%
over average net sales of the previous four periods of USD -38.07 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -175.24 MM has Fallen at -386.89%
over average net sales of the previous four periods of USD -35.99 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 24.38 MM has Grown at 12.68%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 24.38 MM
in the last five periods and Increased by 12.68% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Pre-Tax Profit
Lowest at USD -179.09 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -175.24 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
